摘要 |
The present invention is directed to methods and compositions for reduction of uric acid levels in subjects, and methods and compositions that are useful for treating, suppressing and/or preventing afflictions related to elevated uric acid levels in subjects. The methods comprise administering to the subject an effective amount of compound I, or a pharmaceutically acceptable salt or hydrate thereof, or a composition comprising compound I, or a pharmaceutically acceptable salt or hydrate thereof, and a pharmaceutically acceptable carrier. The compositions and/or methods may further comprise administering to the subject an effective amount of xanthine oxidase inhibitor such as allopurinol, or a pharmaceutically acceptable salt or hydrate thereof. |
申请人 |
BIOCRYST PHARMACEUTICALS, INC.;HOLLISTER, ALAN;SHERIDAN, WILLIAM, P.;BANTIA, SHANTA;FLYNT, AMY;ELDER, JENNA;WAUGH, ANITA;LYMAN, SCOTT |
发明人 |
HOLLISTER, ALAN;SHERIDAN, WILLIAM, P.;BANTIA, SHANTA;FLYNT, AMY;ELDER, JENNA;WAUGH, ANITA;LYMAN, SCOTT |